pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
ruxotemitide
Oncopore (ruxotemitide [INN])
Metastatic Melanoma
Lytix Biopharma ASA
0 catalysts
Preclinical
sabizabulin hydrochloride
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$VERUVERU INC.
0 catalysts
Phase 2
sacituzumab drozuntecan
sacituzumab drozuntecan [INN]
Epithelial Ovarian Cancer
$BNTXBioNTech SE
0 catalysts
← prev
page 57 of 62
next →
131
Pain89
Neurology1
Phase 3
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRKMerck & Co., Inc.
0 catalysts
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVBNuvation Bio Inc.
0 catalysts
Phase 2
sapablursen sodium
Polycythemia Vera
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Granulocyte-macrophage colony-stimulating factor receptor
Partner Therapeutics Inc
0 catalysts
Phase 2
satricabtagene autoleucel
Adenocarcinoma Of The Gastroesophageal Junction
CARsgen Therapeutics Holdings Ltd
0 catalysts
Phase 2
savolitinib
Non-Small Cell Lung Cancer
Hepatocyte growth factor receptor
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
sepantronium bromide
Burkitt Lymphoma
Beijing zhikangbo Medical Oncology Research Co Ltd
0 catalysts
Phase 2
seviprotimut-L
Melanoma
Polynoma LLC
0 catalysts
Phase 2
siG-12D-LODER
Pancreatic Ductal Adenocarcinoma
$SLXNSilexion Therapeutics Corp
0 catalysts
Phase 2
silevertinib
Non-Small Cell Lung Cancer
$BDTXBlack Diamond Therapeutics, Inc.
0 catalysts
Phase 2
silmitasertib
silmitasertib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Senhwa Biosciences Inc
0 catalysts
Phase 2
sintilimab
Angiosarcoma
Programmed cell death protein 1
Innovent Biologics Inc
0 catalysts
Marketed
sipuleucel-T
Provenge (sipuleucel-T)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Dendreon Pharmaceuticals LLC
0 catalysts
Phase 1
siremadlin succinate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$NVSNOVARTIS AG
0 catalysts
Phase 2
sirexatamab
sirexatamab [INN]
Endometrial Cancer
Leap Therapeutics Inc
0 catalysts
Marketed
sirolimus albumin-bound
Fyarro (sirolimus)
Mesenchymal Tumor
Kaken Pharmaceutical Co Ltd
0 catalysts
Phase 2
sirpiglenastat
Metastatic Hepatocellular Carcinoma (HCC)
Dracen Pharmaceuticals Inc
0 catalysts
Phase 3
sitravatinib malate
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
sofetabart mipitecan
Fallopian Tube Cancer
Eli Lilly and Co
0 catalysts
Phase 2
solnerstotug
solnerstotug [INN]
Bile Duct Cancer (Cholangiocarcinoma)
$SNSESensei Biotherapeutics, Inc.
0 catalysts
Phase 3
sonesitatug vedotin
Adenocarcinoma Of The Gastroesophageal Junction
$AZNASTRAZENECA PLC
0 catalysts
Marketed
sonidegib phosphate
Odomzo (sonidegib phosphate)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Sun Pharmaceutical Industries Ltd
0 catalysts
pre_registration
sonrotoclax
Mantle Cell Lymphoma
$ONCBeOne Medicines Ltd.
0 catalysts
Marketed
sorafenib tosylate
Nexavar (sorafenib tosylate)
Hepatocellular Carcinoma
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Marketed
sotorasib
Lumakras (sotorasib)
Metastatic Colorectal Cancer
GTPase KRas
$AMGNAMGEN INC
0 catalysts
Phase 1
sovilnesib
sovilnesib [INN]
Ovarian Cancer
Volastra Therapeutics Inc
0 catalysts
Phase 3
spartalizumab
Pancreatic Cancer
Programmed cell death protein 1
$NVSNOVARTIS AG
0 catalysts